002424SZSE

Special Report on the Annual Deposit, Management, and Use of Raised Funds

ST Bailing Co., Ltd.·

✨ AI Summary

This report details the annual status of raised funds for Guizhou Bai Ling Enterprise Group Pharmaceutical Co., Ltd. It covers the total amount raised, its management through special accounts, and its utilization in various investment projects. The company confirms no significant issues in fund usage or disclosure for the period, with all raised funds accounted for.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Special Report on the Annual Deposit, Management, and Use of Raised Funds

The company and all members of its board of directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.

In accordance with the "Supervisory Rules for Raised Funds of Listed Companies" (CSRC Announcement [2025] No. 10) and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies (2025 Revision)" (Shenzhen Securities [2025] No. 480), this report provides a special statement on the deposit and use of the company's raised funds for the year 2025.

I. Basic Situation of Raised Funds

(I) Amount of Funds Actually Raised and Time of Arrival

Approved by the China Securities Regulatory Commission (CSRC) document (2010) No. 629 and agreed by the Shenzhen Stock Exchange, the company publicly issued 37 million ordinary shares (A shares) to the public through offline inquiry and allocation combined with online pricing, at an issue price of RMB 40.00 per share, raising a total of RMB 1,480,000,000.00. After deducting underwriting and sponsorship fees of RMB 86,062,445.00, the raised funds amounted to RMB 1,393,937,555.00, which was remitted to the company's special account for raised funds by the lead underwriter, Hongyuan Securities Co., Ltd., on May 27, 2010. After further deducting online issuance fees, prospectus printing fees, audit fees, legal fees, appraisal fees, and other external expenses directly related to the issuance of equity securities, totaling RMB 12,910,259.59, the net amount of raised funds is RMB 1,381,027,295.41. The arrival of these raised funds has been verified by Tianjian Zhengxin Certified Public Accountants Co., Ltd., which issued the "Capital Verification Report" (Tianjian Zhengxin Audit [2010] General Word No. 030028).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…